Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Businesswire

04:40 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Businesswire" found in our extensive news archives from over 250 global news sources.

More Information about Businesswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Businesswire for you to read. Along with our medical data and news we also list Businesswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of Businesswire Companies for you to search.

Showing News Articles 1–25 of 20,000+ from Businesswire

Wednesday 17th October 2018

Congenica Earns Major Role in Supporting World’s First Routine National Genomic Medicine Service

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic Medicine S...

Bicycle Therapeutics Announces Presentation at the Royal Society

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycles®) product platform, announced that Chief Executive Officer Kevin Lee, Ph.D., will give a presentation at the “Delivery of Novel Therapies in the 21st Century” conference, hosted by the Royal Society and Academy of Me...

WHOOP, the Human Performance Company, Launches in Europe

Used by the world’s top performers, WHOOP enables consumers to reach their highest potential by better understanding their bodies WHOOP, the human performance company, is now available to European consumers for the first time. Launched in the US in 2014, WHOOP is now shipping to countries throughout Europe via the WHOOP website. Initial countr...

Biogen and Samsung Bioepis Announce European Launch of IMRALDI™(adalimumab), Solidifying Leadership in European Anti-TNF Market

IMRALDITM (adalimumab), a biosimilar referencing HUMIRA® i, is the third anti-TNF biosimilar developed by Samsung Bioepis to be commercialized by Biogen across Europe, following BENEPALITM (etanercept) and FLIXABITM (infliximab) Biogen and Samsung Bioepis were the first in Europe to receive approvals for b...

DIA Drives Debates and Solutions at the Crossroads of Healthcare

DIA Europe 2019 annual meeting heads to Vienna, Austria in February DIA, founded as the Drug Information Association, announced three keynote speakers for the upcoming

Karuna Appoints Jeff Jonas, M.D., to Board of Directors

Industry leader brings extensive experience in building and leading clinical development programs for central nervous system disorders Karuna Pharmaceuticals, Inc. (“Karuna”), focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by psychosis and cognitive impairment, today announced the ...

Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health

Ferring will access Evotec’s integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates Evotec will apply its drug discovery platform to design novel and efficacious treatments Collaboration demonstrates Ferring’s commitment to working wit...

Walmart and Sam’s Club Associates, Customers and Members Raise More Than $1 Billion for Sick and Injured Kids

Amount represents largest cash amount ever raised by a company for a nonprofit Walmart and Sam’s Club associates, customers and members recently made history by raising more than $1 billion for Children’s Miracle Network Hospitals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016006...

Tuesday 16th October 2018

MedPharm Awarded Colorado’s First Cannabis Research License

MedPharm, a leading medical cannabis grow, R&D laboratory and compounding facility, announced today that it has been awarded the first cannabis research license by the state of Colorado. To get the license, the state looked at the applicant’s capabilities to successfully develop and conduct research. This press release features multimedia. View the fu...

UnitedHealth Group Donates $500,000 to Help Residents of Florida Gulf Coast Region Affected by Hurricane Michael

UnitedHealth Group deploying health care delivery capabilities in affected areas Company also offers 1:1 match for employee donations supporting disaster-relief efforts UnitedHealth Group (NYSE: UNH) and its UnitedHealthcare and Optum businesses are donating $500,000 to help residents of the Florida Gulf Coast ...

Celebrity Plastic Surgeon & Reality Star Dr. Justin R. Johnsen Joins the WAVE Plastic Surgery Team

Wave Plastic Surgery Welcomes Justin R. Johnsen, MD Dr. Johnsen is the first Board Certified Ophthalmologist and Oculoplastic Surgeon to join the growing practice. WAVE Plastic Surgery, the largest plastic surgery practice in the US specializing in Asian and Endoscopic plastic surgery, is pleased to announce the addition of Dr. Justi...

Humavox Unveils the POD Wireless Charger at EUHA 2018 to Seamlessly Charge Every Type of Hearing Aid

Israeli startup further expands its ETERNA® advanced technology in the hearing aid industry for an innovative, portable, and easy-to-use wireless charging solution Humavox (http://www.humavox.com/), the leader in wireless chargi

Aetna to Announce Third-Quarter 2018 Results

Aetna (NYSE: AET) today announced that third-quarter 2018 results will be made public on Tuesday, October 30, at 6:30 a.m. ET. Given the pending transaction with CVS Health, Aetna will not host a conference call in conjunction with its earnings release. About AetnaAetna is one of the nation’s leading diversified health care benefits compa...

Lantheus Holdings to Host Third Quarter 2018 Earnings Conference Call on October 30, 2018 at 4:30 p.m. Eastern Time

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call at 4:30 p.m. ET on Tuesday, October 30, 2018, to discuss its financial and operating results for the third quarter of 2018. To access the live conference call via telephone, please dial 1-866-498-8390 (U.S. callers) or 1-678-509-75...

vTv Therapeutics to Deliver Two Presentations at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Results of the Azeliragon Phase 3 STEADFAST Trial to be Presented during Oral Session Subgroup Data Discussing the Effect of Azeliragon in Patients with Dementia and Diabetes to be Presented during Poster Session vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage

Global Medical REIT Inc. Schedules Release of its 2018 Third Quarter Financial Results and Conference Call

Conference Call Scheduled for Tuesday, November 6, 2018 at 9:00 a.m. ET Global Medical REIT Inc. (NYSE: GMRE) (the “Company”), a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share, ...

Communication Patterns in EHRs Have Surprising Impact on Outcomes for Patients With Diabetes, AJMC® Researchers Say

Casting messages widely throughout an electronic health record instead of using more focused direct messaging in diabetes care leads to more hospital visits and higher medical costs, according to a study published in the current issue of The American Journal of Managed Care®. One of the promises of health information technology is that it can improve ...

AmpliPhi Biosciences Announces Closing of Public Offering

AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for patients with serious and life-threatening antibiotic-resistant bacterial infections, today announced the closing of its previously announced underwritten public offering. Gross proceeds to AmpliPhi fro...

Fitbit Schedules Q318 Financial Results for October 31, 2018

Fitbit (NYSE: FIT), the leading global wearables brand, today announced that it expects to release results for its third quarter 2018 on Wednesday, October 31, after market close. In conjunction with a press release, management will host a conference call at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time that afternoon. A live webcast of the...

Vertex to Announce Third Quarter 2018 Financial Results on October 24

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2018 financial results on Wednesday, October 24, 2018 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The confere...

Pathway OME Announces Strategic Partnership with Standard Process and Rainbow Genomics

Pathway OME announces their strategic partnership with Standard Process and Rainbow Genomics, respectively. Pathway OME is the leading genetic wellness company for nutrition, exercise, skincare and Artificial Intelligence (AI), used to help guide lifestyle, diet and nutritional supplement decisions to improve the overall health and well-being of patients. ...

Humana Again Earns Top Gold Status in the American Heart Association’s Workplace Health Achievement Index

Awards honor companies that build and maximize an effective workplace culture of health Humana Inc. (NYSE: HUM) has again earned top Gold status in the American Heart Association’s Workplace Health Achievement Index, a self-assessment scorecard that measures the comprehensiveness and quality of a company’s workplace health program, and the o...

Omega Announces Quarterly Common Stock Dividend and Schedules Third Quarter Earnings Release Date and Conference Call

Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company’s Board of Directors declared a common stock dividend of $0.66 per share. The common stock dividend is payable Thursday, November 15, 2018 to common stockholders of record as of the close of business on Wednesday, October 31, 2018. Third Quarter Earnings Release and Con...

Nashville-based EvidenceCare Welcomes New Board Member, Judson Ivy

Nashville-based healthcare startup EvidenceCare announced this week the addition of Judson Ivy, CEO of Ensemble Health Partners, to its board of directors. EvidenceCare, a patient-focused clinical decision support tool for clinicians, was conceived in 2014 to solve a fundamental need for healthcare providers to find and quickly digest the latest t...

On World Food Day, World Finance Donates Equivalent of 300,000 Meals to Feeding America Affiliates in Three U.S. Cities

$75,000 Donation Contributes to World Food Day #ZeroHunger Effort In recognition of today being World Food Day, World Finance and its parent company, World Acceptance Corporation, announced a $75,000 donation and held mobile food pantries to help alleviate hunger in three cities – St. Louis, New Orleans and Greenville, SC – where the 15-state insta...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks